Moxifloxacin is a fluoroquinolone antibacterial agent with a broad spectrum of activity. It falls in the category of 4th generation. It has a better effects against gram-positive bacteria as compared to ciprofloxacin.
Effects:
It has following effects.
1.For the treatment of respiratory tract infections including acute exacerbations of chronic bronchitis.
2.Community-acquired pneumonia.
3.Acute bacterial sinusitis.
4.It is also indicated for the treatment of uncomplicated skin and skin structure infections.
5.In contrast to several other fluoroquinolones, it appears to have a low propensity for causing phototoxic and central nervous system excitatory effects. Complicated intra abdominal infection.